Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Good
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
ablation, absorption, ago, Celerian, ciliary, coagulation, criteria, cyclophotocoagulation, dermatology, disposition, ear, endo, excision, expert, expressly, GBA, incision, incisional, Indiana, Iowa, larger, LCD, MAC, Michigan, Missouri, Nebraska, Noridian, nose, Palmetto, pulled, refractory, rescind, scope, soft, throat, TLT, transscleral, vaporization, vessel, WPS
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view